Doxycycline Dosing for Acne
Recommended Dosing
For adults and children over 100 pounds with moderate to severe acne, start doxycycline at 200 mg on day one (given as 100 mg every 12 hours), then continue with 100 mg daily as maintenance therapy. 1
Standard Dosing by Weight
Adults and children >100 pounds: 200 mg loading dose on day 1 (split as 100 mg twice daily), followed by 100 mg daily maintenance 1
Children ≥8 years and <100 pounds: 2 mg/lb body weight divided into 2 doses on day 1, then 1 mg/lb daily (as single dose or divided into 2 doses) 1
Children <8 years: Contraindicated due to risk of permanent tooth discoloration and enamel hypoplasia 1
Alternative Subantimicrobial Dosing
Modified-release doxycycline 40 mg once daily is an effective alternative that reduces gastrointestinal side effects while maintaining efficacy. 2, 3
This subantimicrobial dose (20 mg twice daily or 40 mg once daily) has demonstrated significant efficacy in moderate inflammatory acne with 84% reduction in papules and 90% reduction in pustules 2, 4
The modified-release 40 mg formulation showed comparable efficacy to standard 100 mg dosing but with markedly fewer drug-related adverse events, similar to placebo rates 3
However, standard 100 mg dosing remains the guideline-recommended first-line dose per the American Academy of Dermatology 1, 2
Mandatory Combination Therapy
Doxycycline must never be used as monotherapy—always combine with topical benzoyl peroxide and/or a topical retinoid to prevent antibiotic resistance. 1, 2
The American Academy of Dermatology explicitly states that systemic antibiotics should be combined with topical retinoid and benzoyl peroxide 2
Concomitant topical therapy should continue as maintenance after completing systemic antibiotic therapy 2
Monotherapy use should be avoided to prevent bacterial resistance development 1, 2
Treatment Duration and Monitoring
Limit treatment to the shortest possible duration, with mandatory reevaluation at 3-4 months to assess response and minimize bacterial resistance. 2, 5
Continue maintenance dosing until clinical improvement allows discontinuation 1
If inadequate response after 3-4 months, consider switching to alternative therapy or escalating to isotretinoin 2
The combination with topical benzoyl peroxide helps prevent resistance development during treatment 5
Critical Safety Considerations
Absolute Contraindications
- Pregnancy (Category D): Contraindicated—can cause fetal harm 1, 2
- Breastfeeding: Distributed into breast milk; discontinue nursing or the drug 1
- Age <8 years: Risk of permanent tooth discoloration and enamel hypoplasia 1, 2
- Tetracycline hypersensitivity 1
Common Adverse Effects
- Gastrointestinal disturbances: More frequent than with minocycline, particularly at higher doses (nausea, vomiting, diarrhea, esophagitis) 1, 2
- Photosensitivity: More common with doxycycline than minocycline—counsel patients on sun protection 1, 2
- Esophageal ulceration: Take with adequate water and avoid lying down immediately after 1
Serious but Rare Complications
- Stevens-Johnson syndrome, toxic epidermal necrolysis 1
- Benign intracranial hypertension (pseudotumor cerebri) 1
- Hemolytic anemia, thrombocytopenia 1
Drug Interactions
- Antacids (aluminum, calcium, magnesium): Significantly reduce absorption 1, 2
- Hormonal contraceptives: May reduce efficacy—counsel on backup contraception 1, 2
- Oral anticoagulants: Enhanced anticoagulant effect 1, 2
- Iron preparations: Reduced doxycycline absorption 1, 2
- Proton-pump inhibitors: May reduce absorption 1
Clinical Pearls
Doxycycline is primarily hepatically metabolized and can be used safely in renal impairment 2
The American Academy of Dermatology gives doxycycline a strong recommendation with moderate certainty of evidence for moderate to severe inflammatory acne 2
Doxycycline has demonstrated superiority over azithromycin in randomized controlled trials 2
For females with hormonal acne components, consider combined oral contraceptives or spironolactone as adjunctive therapy 2
For severe acne failing standard oral antibiotics, strongly consider isotretinoin referral 2